STK40 Antikörper (Middle Region) (Cy3)
Kurzübersicht für STK40 Antikörper (Middle Region) (Cy3) (ABIN8036139)
Target
Alle STK40 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Verwendungszweck
- Anti-STK40 Antibody Cy3 Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence in the middle region of human STK40.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- STK40 (serine/threonine Kinase 40 (STK40))
-
Andere Bezeichnung
- STK40
-
Hintergrund
-
Background: Predicted to enable ATP binding activity, protein serine kinase activity, and protein serine/threonine kinase activity. Predicted to be involved in regulation of MAPK cascade. Predicted to act upstream of or within several processes, including glycogen metabolic process, lung development, and respiratory system process. Located in cytosol and nucleoplasm.
Gene Full Name: serine/threonine kinase 40
-
Gen-ID
- 83931
-
UniProt
- Q8N2I9
Target
-